82304-99-2

Usage

Uses

Used in Pharmaceutical Industry:
3-Formyl-4-hydroxybenzoic acid ethyl ester is used as an active pharmaceutical ingredient for its antioxidant and anti-inflammatory properties, contributing to the development of new drugs and formulations that can address various health conditions.
Used in Cosmetic Industry:
In the cosmetic industry, 3-Formyl-4-hydroxybenzoic acid ethyl ester is used as a key ingredient in skincare products and topical medications. Its antioxidant and anti-inflammatory properties make it beneficial for skin health, helping to reduce inflammation and protect the skin from oxidative stress.
Used in Organic Synthesis:
3-Formyl-4-hydroxybenzoic acid ethyl ester is utilized as a starting material or intermediate in organic synthesis, allowing for the creation of a variety of chemical compounds with diverse applications.
Used in Drug Development:
Due to its unique chemical structure and pharmacological properties, 3-Formyl-4-hydroxybenzoic acid ethyl ester is employed in drug development for the discovery and design of novel therapeutic agents with potential applications in treating various diseases and conditions.

InChI:InChI=1/C10H10O4/c1-2-14-10(13)7-3-4-9(12)8(5-7)6-11/h3-6,12H,2H2,1H3

Upstream product

• 120-47-8 Ethyl 4-hydroxybenzoate 
• 50-00-0 formaldehyd 
• 64-17-5 ethanol 
• 584-87-2 3-formyl-4-hydroxybenzoic acid 
• 100-97-0 hexamethylenetetramine 

Downstream Products

• 122136-03-2 ethyl 3-formyl-4-methoxybenzoate 
• 527681-40-9 ethyl 4-(allyloxy)-3-formylbenzoate 
• 527681-37-4 N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-2H-chromene-6-carboxamide-fumarate 
• 1360060-12-3 ethyl 3-[(E)-2-(4-chlorophenyl)vinyl]-4-hydroxybenzoate 
• 858124-17-1 ethyl (E)-3-[2-(4-chlorophenyl)vinyl]-4-methoxybenzoate 
• 1374791-85-1 3-[(E)-2-(4-chlorophenyl)vinyl]-4-methoxy-benzoyl chloride 
• 858124-06-8 5-ethoxycarbonyl-2-methoxybenzoic acid 
• 858124-09-1 ethyl 3-[(4-chlorophenyl)carbamoyl]-4-methoxybenzoate 
• 858124-10-4 3-[(4-chlorophenyl)carbamoyl]-4-methoxybenzoic acid 
• 1360060-63-4 ethyl 3-[(E)-2-(4-chlorophenyl)vinyl]-4-ethoxybenzoate 
• 1360060-64-5 ethyl 3-[(E)-2-(4-chlorophenyl)vinyl]-4-propoxybenzoate 
• 1360060-55-4 3-[(E)-2-(4-chlorophenyl)vinyl]-4-propoxybenzamide 
• 1360060-57-6 3-[(E)-2-(4-chlorophenyl)vinyl]-4-[2-(2-hydroxyethoxy)ethoxy]benzamide 
• 1360060-59-8 3-[(E)-2-(4-chlorophenyl)vinyl]-4-(2-dimethylaminoethoxy)benzamide 

Relevant academic research and scientific papers

CARBOXAMIDE AND SULFONAMIDE DERIVATIVES USEFUL AS TEAD MODULATORS

The invention is concerned with the compounds of formula (I) and formula (II): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of using the compounds of formula (I) and formula (II) as well as pharmaceutical compositions containing such compounds. The compounds are useful in treating diseases and conditions mediated by TEAD, such as cancer.

Synthesis and studies of photochromic properties of spirobenzopyran carboxy derivatives and their model compounds as potential markers

A number of photochromic markers, viz., spirobenzopyrans containing one or two active carboxy groups attached directly or through a spacer, as well as their model derivatives, were synthesized. The obtained compounds were characterized by instrumental methods of analysis. Spectrokinetic methods were used to study the behavior of the spirobenzopyran markers and the model derivatives in solutions in EtOH and toluene.

A novel dinuclear Schiff-base copper(II) complex modified electrode for ascorbic acid catalytic oxidation and determination

A new dinuclear copper salicylaldehyde-glycine Schiff-base complex [Cu 2(Sal-Gly)2(H2O)2] was synthesized and structurally characterized. [Cu2(Sal-Gly)2(H 2O)2] crysta

Angiogenesis inhibitors identified by cell-based high-throughput screening: Synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation

Proliferation of endothelial cells is critical for angiogenesis. We report orally available, in vivo active antiangiogenic agents which specifically inhibit endothelial cell proliferation. After identifying human umbilical vein endothelial cell (HUVEC) pr

An efficient one-pot synthesis of pyrrolo[4,3,2-ij]isoquinoline derivatives by a consecutive aza-wittig/electrocyclic ring-closure/intramolecular acylation process

Iminophosphorane, ethyl 5-ethoxycarbonyl-2-methoxy-α-[(triphenylphosphoranylidene)amino]cinn amate (4) reacts with aliphatic and aromatic isocyanates in toluene at 170°C to give directly the corresponding pyrrolo[4,3,2-ij]isoquinolines 8 in moderate yields.